#362 - Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis: Results From the Open-Label Run-In Period of JADE REGIMEN
Mark G. Lebwohl, Margitta Worm, Linda F. Stein Gold, Christine Bangert, Peter Schmid-Grendelmeier, Tahira Khan, Pinaki Biswas, Marco DiBonaventura, Gary Chan, Ketti Terry, Hernan Valdez, Claire Clibborn8
#364 - Content Validity of the Atopic Dermatitis Symptom Scale (ADerm-SS) and Atopic Dermatitis Impact Scale (ADerm-IS) in Adolescents to Assess the Symptoms and Impacts of Atopic Dermatitis
Jonathan I. Silverberg, Eric L. Simpson, Megan McLafferty, Sylvia Su, Paolo Medrano, Brian M. Calimlim, Amy S. Paller
#365 - Psychometric Evaluation of Three Patient-Reported Outcome Questionnaires Assessing the Symptoms and Impacts of Atopic Dermatitis in Adults and Adolescents
Jonathan I. Silverberg, Eric L. Simpson, Leighann Litcher-Kelly, Jeffrey McDonald, Brian M. Calimlim, Yael A. Leshem
#367 - Examining the Relationships Among Abrocitinib Monotherapy, Pruritus Severity, and Skin Clearance in Patients With Moderate-to-Severe Atopic Dermatitis: Results From JADE MONO-1 and JADE MONO-2
Eric L. Simpson, Gil Yosipovitch, Sonja Ständer, Jonathan I. Silverberg, Jacob P. Thyssen, Shawn G. Kwatra, Thomas Luger, Emma Guttman-Yassky, Wynnis L. Tom, Andrew G. Bushmakin, Joseph C. Cappelleri, Gary Chan, Claire Feeney, Natalie Yin, Hernan Valdez, Marco DiBonaventura, Daniela E. Myers
#369 - Sleep Health and Attention Dysregulation in a National Study of Infants and Preschool Aged Children with Atopic Dermatitis (AD)
Nina Y. Zhou, BA, Amanda Nili, BA, Courtney Blackwell, PhD, Nonye Ogbuefi, BA, Peter Cummings, MPH, Jin-Shei Lai, PhD, OTR, James W. Griffith, PhD, Amy S. Paller, MD, MS, Lauren Wakschlag, PhD, Anna B. Fishbein, MD, MS
#375 - Tralokinumab prevents flares in moderate-to-severe atopic dermatitis: post hoc analyses of a randomized phase 3 clinical trial (ECZTRA 3)
Jonathan I. Silverberg, Sebastien Barbarot, Julia Welzel, Mahreen Ameen, Jacob P. Thyssen, Mark Lomaga, Christina Kurre Olsen, Thomas Mark, Joshua Corriveau, and Joseph F. Merola